Pulmonary Disease Doctors in Jamaica Plain, MA - Medicare Status, Address, Contact

1 Pulmonary Disease doctors found. Showing 1 - 1

Raymond L H Murphy, M.D.
Internal Medicine - Pulmonary Disease
Medicare: Not Enrolled in Medicare
Practice Location: Faulkner Hospital, 1153 Centre Street, Jamaica Plain, MA 02130
Phone: 617-522-5800

News Archive

Study reveals high rate of parental depression in first year after child's birth

More than one-third of mothers and about one-fifth of fathers in the United Kingdom appear to experience an episode of depression between their child's birth and 12th year of age, with the highest rates in the first year after birth, according to a report posted online today that will appear in the November print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

Scientists develop artificial neurons on silicon chips

Artificial neurons on silicon chips that behave just like the real thing have been invented by scientists - a first-of-its-kind achievement with enormous scope for medical devices to cure chronic diseases, such as heart failure, Alzheimer's, and other diseases of neuronal degeneration.

Monitoring air pollution now possible with technological advances in air quality measurement methods

Launching a natural research experiment in Kathmandu, Nepal, this month using advanced monitoring methods to assess health risk from air pollution, environmental health scientist Rick Peltier at the University of Massachusetts Amherst hopes to demonstrate for the first time in a real-world setting that air pollution can and should be regulated based on toxicology variables rather than simply on the volume of particles in the air.

PHE renews contract for Down's, Edwards' and Patau's syndromes antenatal screening programme

Public Health England has renewed its contract with Plymouth University Peninsula Schools of Medicine and Dentistry to provide the Down's syndrome screening Quality Assurance Support Service for its Down's, Edwards' and Patau's syndromes antenatal screening programme in England.

FDA grants QIDP and Fast Track designation to Nabriva's lefamulin for treatment of CABP, ABSSSI

Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).

Pulmonary Disease Doctors in Jamaica Plain, MA Accepting Medicare